Stephen M. Hicks serves as Executive at IMMUNOTECHNOLOGY CORP, where they oversee executive responsibilities. Since joining the company, Stephen M. Hicks has executed 7 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Oct 21, 2010 involved receiving (via award) 912,897 shares valued at $27.4K.
Stephen M. Hicks currently holds 243,017 shares of IMMUNOTECHNOLOGY CORP (IMUO), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Stephen M. Hicks has been a net neutral trader of IMUO stock. They have purchased $0 and sold $0 worth of shares.
Stephen M. Hicks's most recent insider trade was on Oct 21, 2010, when they sold 912,897 shares at $0.03 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Dec 10, 2009 | TCNH | $0 | Award | 20,661 | $N/A | Discretionary |
| Sep 21, 2009 | TCNH | $0 | Award | 130,246 | $N/A | Discretionary |
| Dec 17, 2008 | TCNH | $1.6K | Award | 22,619 | $0.07 | Discretionary |
| Jul 28, 2008 | "TCNH" | $0 | Award | 10,917 | $N/A | Discretionary |
| Jul 31, 2006 | IMUO | $0 | Other | 5,700,000 | $N/A | Discretionary |